Anja Lorch

4.1k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Anja Lorch is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anja Lorch has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Anja Lorch's work include Testicular diseases and treatments (8 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Sarcoma Diagnosis and Treatment (4 papers). Anja Lorch is often cited by papers focused on Testicular diseases and treatments (8 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Sarcoma Diagnosis and Treatment (4 papers). Anja Lorch collaborates with scholars based in Switzerland, Germany and United Kingdom. Anja Lorch's co-authors include Richard Cathomas, Virginia Hernández, Erik Veskimäe, María J. Ribal, Nigel C. Cowan, Mathieu Rouanne, Éva Compérat, Georgios Gakis, George N. Thalmann and Y. Neuzillet and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Anja Lorch

26 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

2020 1.3k citations J. Alfred Witjes, Harman Max Bruins et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anja Lorch Switzerland	9	1.3k	367	351	343	293	28	1.5k
H.M. Bruins Netherlands	14	1.4k 1.1×	582 1.6×	343 1.0×	343 1.0×	233 0.8×	24	1.7k
Harman Max Bruins Netherlands	13	2.0k 1.5×	664 1.8×	474 1.4×	490 1.4×	326 1.1×	17	2.2k
Beat Foerster Austria	20	974 0.7×	327 0.9×	332 0.9×	310 0.9×	146 0.5×	55	1.3k
Marek Babjuk Czechia	23	1.6k 1.2×	541 1.5×	478 1.4×	378 1.1×	424 1.4×	93	2.1k
Joan Palou Redorta Spain	17	1.3k 1.0×	631 1.7×	296 0.8×	684 2.0×	316 1.1×	65	2.0k
Diane Zipursky Quale United States	11	1.8k 1.4×	672 1.8×	428 1.2×	219 0.6×	272 0.9×	23	2.0k
Ilaria Lucca Switzerland	23	744 0.6×	223 0.6×	456 1.3×	492 1.4×	258 0.9×	70	1.4k
A. Masson-Lecomte France	18	1.7k 1.3×	453 1.2×	462 1.3×	665 1.9×	463 1.6×	87	2.2k
Estefanía Linares Spain	14	2.4k 1.8×	780 2.1×	618 1.8×	669 2.0×	501 1.7×	40	2.8k
Yasunobu Hashimoto Japan	20	563 0.4×	169 0.5×	265 0.8×	630 1.8×	283 1.0×	84	1.2k

Countries citing papers authored by Anja Lorch

Since Specialization

Citations

This map shows the geographic impact of Anja Lorch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Lorch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Lorch more than expected).

Fields of papers citing papers by Anja Lorch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Lorch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Lorch. The network helps show where Anja Lorch may publish in the future.

Co-authorship network of co-authors of Anja Lorch

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Lorch. A scholar is included among the top collaborators of Anja Lorch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Lorch. Anja Lorch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hayoz, Stefanie, Cyrill A. Rentsch, Frank Stenner, et al.. (2025). 3107P Intravesical recombinant BCG followed by perioperative chemo-immunotherapy (chemo-IO) for patients with muscle-invasive bladder cancer (MIBC): Interim analysis of SAKK 06/19 study. Annals of Oncology. 36. S1504–S1504.

Fankhauser, Christian D., Marian S. Wettstein, Ailsa J. Christiansen, et al.. (2024). Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. Urologic Oncology Seminars and Original Investigations. 42(12). 455.e9–455.e13.

Peng‐Keller, Simon, et al.. (2024). Adoption of evidence‐based end‐of‐life and bereavement support to families in cancer care: A contextual analysis study with health professionals. Journal of Clinical Nursing. 33(9). 3599–3614. 3 indexed citations

Lorch, Anja, et al.. (2024). Contextual determinants of guideline-based family support during end-of-life cancer care and subsequent bereavement care: A cross-sectional survey of registered nurses. European Journal of Oncology Nursing. 70. 102555–102555. 3 indexed citations

Powles, Thomas, Yoshiaki Yamamoto, José Muñoz-Langa, et al.. (2024). Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the phase 3 KEYNOTE-361 trial.. Journal of Clinical Oncology. 42(16_suppl). 4518–4518. 1 indexed citations

Sobottka, Bettina, Viola Katharina Vetter, Amir Banaei‐Esfahani, et al.. (2024). Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue. Modern Pathology. 37(10). 100558–100558. 2 indexed citations

Omlin, Aurelius, Richard Cathomas, Gunhild von Amsberg, et al.. (2023). Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 29(10). 1887–1893. 6 indexed citations

Gnannt, Ralph, Michael Hofmann, Olivier de Rougemont, et al.. (2023). Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study. International Journal of Cancer. 153(7). 1397–1405. 8 indexed citations

Menges, Dominik, Aurelius Omlin, Richard Cathomas, et al.. (2023). Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment. European Urology Open Science. 51. 26–38. 4 indexed citations

10.

Papachristofilou, Alexandros, Jens Bedke, Stefanie Hayoz, et al.. (2022). Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial. The Lancet Oncology. 23(11). 1441–1450. 19 indexed citations

11.

Oliveira, Pedro, Anja Lorch, J. Beyer, et al.. (2021). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. Journal of Cancer Research and Clinical Oncology. 147(9). 2671–2679. 8 indexed citations

12.

Lorch, Anja, J. Beyer, Daniel Eberli, et al.. (2020). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: Analysis of published case series data. European Urology Open Science. 21. S243–S243. 2 indexed citations

13.

Kranzbühler, Benedikt, Daniel Eberli, Tullio Sulser, et al.. (2020). Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data. Journal of Cancer Research and Clinical Oncology. 146(11). 2829–2841. 21 indexed citations

14.

Witjes, J. Alfred, Harman Max Bruins, Richard Cathomas, et al.. (2020). European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. European Urology. 79(1). 82–104. 1278 indexed citations breakdown →

15.

Gakis, Georgios, H.M. Bruins, Richard Cathomas, et al.. (2020). European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update. European Urology Oncology. 3(4). 424–432. 21 indexed citations

16.

Bruins, Harman Max, Erik Veskimäe, Virginia Hernández, et al.. (2019). The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel. European Urology Oncology. 3(2). 131–144. 57 indexed citations

17.

Lorch, Anja. (2016). Systemische Therapie des metastasierten Prostatakarzinoms. Der Onkologe. 23(3). 237–250. 1 indexed citations

18.

Burchert, Andreas, Anja Lorch, J. T. Hartmann, et al.. (2010). Clinical relevance of germ cell cancer cells detected by real time PCR in apheresis products of poor risk patients undergoing high dose chemotherapy.. Journal of Clinical Oncology. 28(15_suppl). 4579–4579. 3 indexed citations

19.

Helbling, Daniel, Frank Stenner, Christian Rothermundt, et al.. (2010). Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Medical Weekly. 140(2526). 356–369. 15 indexed citations

20.

Lorch, Anja, et al.. (1978). Reversible acute renal failure associated with chlorthalidone therapy: possible drug-induced interstitial nephritis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 67(1). 17–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact